Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Oct 8 · below the Ichimoku cloud · RSI 30 · MACD below its signal · at its 52-week low
| 16.50 | 52-week high | +242.32% |
| 7.62 | Previous month high | +58.09% |
| 6.53 | Previous month low | +35.48% |
| 6.36 | Previous week high | +32.05% |
| 5.79 | R3 (classic) | +20.06% |
| 5.59 | R2 (classic) | +16.04% |
| 5.40 | Previous day high | +12.03% |
| 5.21 | R1 (classic) | +8.02% |
| 5.01 | Pivot | +4.01% |
| 4.82 | Previous day low | +0.00% |
| 4.82 | Previous week low | +0.00% |
| 4.82 | 52-week low | +0.00% |
| 4.82 | Price now | |
| 4.63 | S1 (classic) | −4.01% |
| 4.43 | S2 (classic) | −8.02% |
| 4.05 | S3 (classic) | −16.04% |
None of the 29 investors followed here reported a position in DRIO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a DRIO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Shaked YoavDirector | Stock Award(Grant) at price 0.00 per share. | 54K | — |
| Sep 23, 2026 | Franco-Yehuda ChenChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 95K | — |
| Sep 23, 2026 | Matheis DennisDirector | Stock Award(Grant) at price 0.00 per share. | 44K | — |
| Sep 23, 2026 | Mcgrath Dennis MDirector | Stock Award(Grant) at price 0.00 per share. | 61K | — |
| Sep 23, 2026 | Palumbo John RDirector | Stock Award(Grant) at price 0.00 per share. | 62K | — |
| Sep 23, 2026 | Stern Adam K.Director | Stock Award(Grant) at price 0.00 per share. | 28K | — |
| Sep 23, 2026 | Karah HilaDirector | Stock Award(Grant) at price 0.00 per share. | 28K | — |
| Sep 23, 2026 | Raphael ErezChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 297K | — |
| Jul 22, 2026 | Matheis DennisDirector | Purchase at price 6.93 per share. | 14.4K | $100.00K |
| Sep 17, 2025 | Stern Adam K.Director | Conversion of Exercise of derivative security at price 16.60 - 40.40 per share. | 20.2K | $615.13K |
| Sep 10, 2025 | Shaked YoavDirector | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Sep 10, 2025 | Franco-Yehuda ChenChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 5K | — |
| Sep 10, 2025 | Matheis DennisDirector | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Sep 10, 2025 | Nelson Steven CharlesPresident | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| Sep 10, 2025 | Mcgrath Dennis MDirector | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Sep 10, 2025 | Stern Adam K.Director | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Sep 10, 2025 | Karah HilaDirector | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Sep 10, 2025 | Leisure Lawrence B.Director | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Sep 10, 2025 | Raphael ErezChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 60K | — |
| Aug 26, 2025 | Nelson Steven CharlesPresident | Purchase at price 0.53 per share. | 40K | $21.20K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -12.0 | 19.5 | -33.0 | -10.9 | 8.5 | -14.8 | 10.2 | 1.4 | -10.2 | -27.2 | −57.6% | ||
| 2025 | -21.1 | 12.3 | -12.1 | 16.8 | 0.0 | -6.3 | -14.5 | -17.0 | 82.4 | -19.4 | -14.7 | -4.7 | −27.6% |
| 2024 | 9.9 | 7.4 | -24.6 | -7.2 | 0.7 | -16.8 | -9.2 | -25.0 | 38.3 | -14.3 | -17.8 | -0.4 | −54.3% |
| 2023 | 29.4 | -17.0 | -10.4 | -18.2 | 15.7 | 2.8 | -7.0 | -16.1 | 4.8 | -61.0 | -5.5 | 42.1 | −59.8% |
| 2022 | -32.4 | -16.8 | -20.0 | -15.1 | 34.1 | -7.7 | -0.5 | -21.9 | -2.9 | -4.3 | 12.0 | -13.7 | −67.0% |
| 2021 | 51.6 | 22.8 | -27.6 | 12.6 | -25.0 | 31.3 | -30.5 | -9.1 | 1.2 | 19.8 | -4.4 | -17.0 | −9.2% |
| 2020 | 16.9 | -4.8 | -7.0 | 13.7 | -17.1 | -0.8 | 95.3 | 31.6 | 2.8 | -39.4 | 23.5 | 13.8 | +117.8% |
| 2019 | -4.6 | -4.7 | 4.5 | 12.6 | -40.2 | -6.2 | 31.2 | -34.4 | -24.0 | -19.4 | 1557.1 | 61.6 | +745.4% |
| 2018 | -5.1 | -8.4 | 10.6 | 17.5 | -11.6 | -20.0 | 6.3 | -19.1 | -11.8 | 3.1 | -26.0 | 4.9 | −51.6% |
| 2017 | 9.2 | 11.5 | -24.0 | -6.6 | -24.5 | 2.8 | 26.1 | -23.6 | -12.4 | -4.3 | -13.6 | 5.4 | −50.7% |
| 2016 | 21.6 | -4.2 | 2.6 | -15.5 | -16.1 | -2.7 | -9.6 | -4.7 | 6.2 | −24.6% |
TimeframesDown on all 4 timeframes: no timeframe is holding up.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Buy / hold / sell counts